Loss of E-cadherin expression in early gastric cancer

Histopathology

Volumn 34, Issue 5, 1999, Pages 410-415

  Blok, P ^a,e   Craanen, M E ^b   Dekker, W ^c   Tytgat, G N J ^d  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Kennemer Gasthuis Locatie EG ^*  (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e LEYENBURG HOSPITAL   (Netherlands)

Author keywords

Carcinoma; E cadherin; Stomach

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH BIOPSY; STOMACH CARCINOMA; SURVIVAL TIME;

CADHERINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; PRECANCEROUS CONDITIONS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 0033021649     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1999.00652.x     Document Type: Article

References (45)

1. 1. Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K, Takeichi M. Transformation of cell adhesion properties by exogenously introduced e-cadherin cDNA. Nature 1987; 329; 341-343.
2. 2. Hatta K, Takeichi M. Expression of N-cadherin adhesion molecules associated with morphogenetic events in chick development. Nature 1986; 320; 447-449.
3. 3. Nose A, Nagafuchi A, Takeichi M. Isolation of placental cadherin cDNA, identification of a novel gene family of cell-cell adhesion molecules. EMBO J. 1987; 6; 3655-3661.
4. 4. Gallin WJ. Sorkin BC, Edelman G, Cunningham BA. Sequence analysis of a cDNA clone encoding the liver cell adhesion molecule, L-CAM. Proc. Natl. Acad. Sci. USA 1987; 84; 2808-2818.
5. 5. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 139; 17-23.
6. 6. Behrens J. Mareel MM, van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 1989; 108; 2435-2447.
7. 7. Mareel M, Bracke M, van Roy F. Invasion promotor versus invasion suppressor molecules: the paradigm of E-cadherin. Mol. Biol. Rep 1994; 19; 45-67.
8. 8. Shino Y, Watanabe A, Yamada Y et al. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 1995; 76; 2193-2201.
9. 9. Yonemura Y, Nojima N, Kaji M et al. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 1995; 76; 941-945.
10. 10. Oka H, Shiozaki H, Kobayashi K et al. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Archiv (A) Pathol. Anat. 1992; 421; 149-156.
11. 11. Lauren P. The two histological main types of gastric carcinoma; diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 1965; 64; 31-49.
12. 12. Rodenhuis S, Slebos RJC. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 1992; 52; 2665s-2669s.
13. 13. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya N. Detection of ras gene mutation in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990; 5; 1037-1043.
14. 14. Craanen ME, Blok P, Top et al. Absence of ras gene mutations in early gastric carcinomas. Gut 1995; 37; 758-762.
15. 15. Lipponen P, Saarelainen E, Aaltomaa S, Syrjänen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J. Pathol. 1994; 174; 101-109.
16. 16. Bringuier PP, Umbas R, Schaafsma E, Karthaus HFM, DeBruyne FMJ, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 1993; 53; 3241-3245.
17. 17. Mattijssen V, Peters HM, Schalkwijk L et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer 1993; 55; 580-585.
18. 18. Craanen ME. Dekker W, Ferwerda J. Blok P, Tytgat GNJ. Early gastric cancer; a clinicopathologic study. J. Clin. Gastroenterol. 1991; 31; 274-283.
19. 19. Kodama Y, Inokuchi K, Soejima K, Matsusaka T, Okamura T. Growth patterns and prognosis in early gastric carcinoma. Cancer 1983; 51; 320-326.
20. 20. Price AB. The Sydney system; histological division. J. Gastroenterol. Hepatol. 1991; 6; 209-222.
21. 21. Filipe MI. Histochemistry of intestinal mucins. In: Whitehead R, ed. Gastrointestinal and Oesophageal Pathology. 1st edn. Edinburgh. London, Melbourne, New York: Churchill Livingstone, 1989: 71.
22. 22. Watanabe H, Jass JR, Sobin LH, eds. WHO International Histological Classification of Tumors. The Histological Typing of Oesophageal and Gastric Tumors. Berlin, Heidelberg, New York, Paris, Tokyo: Springer-Verlag, 1990.
23. 21. Murakami T. Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. In: Murakami T, ed. Early Gastric Cancer. Gann Monograph on Cancer Research, Vol. 11. Tokyo: University of Tokyo Press, 1971: 53-55.
24. 24. Hsu SM, Raine L, Fanger H. The use of the avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques; a comparison between ABC find unlabeled antibody procedures. J. Histochem. Cytochem. 1985; 19; 577-580.
25. 25. Becker KF, Atkinson MJ, Reich U et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994; 54; 3845-3852.
26. 26. Becker KF, Höfler H. Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J. Natl. Cancer Inst. 1995; 87; 1082-1084.
27. 27. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S, E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J. Cancer Res. 1996; 87; 843-848.
28. 28. Tamura G, Sakata K, Nishizuka S et al. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J. Cancer Res. 1996; 87; 1153-1159.
29. 29. Dogan A, Wang ZD, Spencer J. E-cadherin expression in intestinal epithelium. J. Clin. Pathol 1995; 48; 143-146.
30. 30. Hanby AM, Chinery R, Poulsom R, Playford RJ, Pignatelli M. Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am. J. Pathol 1996; 148; 723-729.
31. 31. Gluck U, Rodriguez-Fernandez JL, Pankov R, Ben Ze'ev A. Regulation of adherens junction protein expression in growth-activated 3T3 cells and in regenerating liver. Exp Cell Res. 1992; 202; 477-486.
32. 32. Silva S, Filipe MI, Pinho A. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow-up study. Gut 1990; 31; 1097-1105.
33. 33. Filipe MI, Munoz N, Matko I et al. Intestinal metaplasia types and the risk of gastric cancer. Int. J. Cancer 1994; 57; 324-329.
34. 34. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32; 1110-1113.
35. 35. Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986; 10; 1271-1277.
36. 36. Ramesar KC, Sanders DS, Hopwood D. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J. Clin. Pathol. 1987; 40; 1287-1290.
37. 37. Mayer B, Johnson JP, Leitl F et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Rev 1993; 53; 1690-1695.
38. 38. Matsuura K, Kawanishi J, Fujii S, Hirano S, Takeichi M, Niitsu Y. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br. J. Cancer 1992; 66; 1122-30.
39. 39. Shimoyama Y, Hirohashi S. Expression of E-and P-cadherin in gastric carcinomas. Cancer Res. 1991; 51; 2185-2192.
40. 40. Syrigos KN, Krausz T, Waxman J et al. E-cadherin expression in bladder cancer using formalin-fixed, paraflin-imbedded tissues: correlation with histological grade, tumour stage and survival. Int. J. Cancer 1995; 64; 367-370.
41. 41. Pignatelli M, Ansari TW, Gunter P et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J. Pathol. 1994; 174; 243-248.
42. 42. Dorudi S, Sheffield JP, Poulsom R, Northover JMA. Hart IR. E-cadherin expression in colorectal cancer. Am. J. Pathol. 1993; 142; 981-986.
43. 43. Becker KF, Atkinson MJ, Reich U et al. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum. Mol. Genet. 1993; 2; 803-804.
44. 44. Yonemura Y, Ninomiya I, Kaji M et al. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal. Cell Pathol. 1995; 8; 177-190.
45. 45. Gabbert HE, Mueller W, Schneiders A et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J. Cancer 1996; 69; 184-189.